Epilepsy in the developing world

Developing countries (DCs) and developed countries have geographic, economic, and social differences. The prevalence and incidence of epilepsy are higher in DCs than in developed countries. However, within DCs, given the high incidence of epilepsy, the prevalence is relatively low, which may be due to high mortality for people with epilepsy (PWE). Neurocysticercosis is one of the main causes of symptomatic epilepsy in many DCs. Prognosis in DCs seems similar to that in developed countries. Because phenobarbital and phenytoin are available and inexpensive, they are the drugs most often used in DCs. The cost of newer antiepileptic drugs and the limited availability of resources for epilepsy care in DCs mean that care for PWE in DCs is marginalized and that many people receive no pharmacologic treatment. The most cost-effective way to decrease the treatment gap in DCs would be to deliver the epilepsy services through primary health care.

[1]  M. Guerreiro,et al.  Recurrence after a First Unprovoked Cryptogenic/Idiopathic Seizure in Children: A Prospective Study from São Paulo, Brazil , 2004, Epilepsia.

[2]  Josemir W Sander,et al.  Prevalence and Pattern of Epilepsy Treatment in Different Socioeconomic Classes in Brazil , 2007, Epilepsia.

[3]  C. Mandlhate,et al.  Management of epilepsy patients in Batamariba district, Togo , 2007, Acta neurologica Scandinavica.

[4]  Josemir W Sander,et al.  Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China , 2006, Epilepsia.

[5]  G. Kabagambe,et al.  Mortality from epilepsy in an onchocerciasis-endemic area in West Uganda. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[6]  A. Winkler,et al.  Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  E. Beghi,et al.  Cross‐Country Measures for Monitoring Epilepsy Care , 2007, Epilepsia.

[8]  E. Perucca.  Treatment of epilepsy in developing countries , 2007, BMJ : British Medical Journal.

[9]  P. N. Banerjee,et al.  CHAPTER 5 ■ INCIDENCE AND PREVALENCE , 2007 .

[10]  P. Jallon,et al.  Episousse: Incidence of Newly Presenting Seizures in Children in the Region of Sousse, Tunisia , 2003, Epilepsia.

[11]  M. Druet‐Cabanac,et al.  Prevalence of Epilepsy in a Rural District of Central Lao PDR , 2006, Neuroepidemiology.

[12]  K. El-Salem,et al.  Risk of seizure recurrence after a first unprovoked seizure: a prospective study among Jordanian children , 2004, Seizure.

[13]  R. Gilman,et al.  Neurocysticercosis: Association between seizures, serology, and brain CT in rural Peru , 2005, Neurology.

[14]  R. Gilman,et al.  Epilepsy and Neurocysticercosis in Atahualpa: A Door‐to‐Door Survey in Rural Coastal Ecuador , 2005, Epilepsia.

[15]  B. Neville,et al.  Prevalence, incidence and risk factors of epilepsy in older children in rural Kenya , 2008, Seizure.

[16]  R. Gilman,et al.  Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case–control study , 2008, The Lancet Neurology.

[17]  W. Hauser,et al.  Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis , 2002, Neurology.

[18]  P. Kowacs,et al.  The role of the irritative zone and of the number and distribution of calcifications in the severity of epilepsy associated with intracranial calcifications. , 2006, Arquivos de neuro-psiquiatria.

[19]  M. Bianchin,et al.  Cognitive performance of patients with mesial temporal lobe epilepsy and incidental calcified neurocysticercosis , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  F. Andermann,et al.  Surgery for pharmacoresistant epilepsy in the developing world: A pilot study , 2009, Epilepsia.

[21]  S. Kochen,et al.  Prevalence and Clinical Features of Epilepsy in Argentina , 2006, Neuroepidemiology.

[22]  H. Meinardi,et al.  The Treatment Gap in Epilepsy: The Current Situation and Ways Forward , 2001, Epilepsia.

[23]  J. Sander,et al.  Overview of the Demonstration Projects , 2002 .

[24]  S. Kochen,et al.  Prevalence and clinical features of epilepsy in Argentina. A community-based study. , 2007, Neuroepidemiology.

[25]  A. Chattopadhyay,et al.  Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[26]  T. Chen,et al.  Mortality in adult patients with epilepsy in Taiwan. , 2005, Epileptic disorders : international epilepsy journal with videotape.

[27]  R. Helbok,et al.  Prevalence of Active Epilepsy in a Rural Area in South Tanzania: A Door‐to‐Door Survey , 2005, Epilepsia.

[28]  B. Neville,et al.  Increased Prevalence of Epilepsy Associated with Severe Falciparum Malaria in Children , 2004, Epilepsia.

[29]  Gagandeep Singh,et al.  Epidemiologic classification of seizures associated with neurocysticercosis: observations from a sample of seizure disorders in neurologic care in India , 2006, Acta neurologica Scandinavica.

[30]  P. Allebeck,et al.  The prevalence of epilepsy in a rural district of Vietnam: A population‐based study from the EPIBAVI project , 2008, Epilepsia.

[31]  G. P. Mondal,et al.  Awareness of warning symptoms and risk factors of stroke in the general population and in survivors stroke , 2007, Journal of Clinical Neuroscience.

[32]  L. Forsgren,et al.  Incidence and prevalence , 2004 .

[33]  R. Marcus,et al.  Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy , 2005, Annals of neurology.

[34]  P. Kwan,et al.  Phenobarbital for the Treatment of Epilepsy in the 21st Century: A Critical Review , 2004, Epilepsia.

[35]  G. Birbeck,et al.  Epilepsy prevalence in rural Zambia: a door‐to‐door survey , 2004, Tropical medicine & international health : TM & IH.

[36]  W. Hauser,et al.  Estimating the incidence of first unprovoked seizure and newly diagnosed epilepsy in the low‐income urban community of Northern Manhattan, New York City , 2008, Epilepsia.

[37]  J. Bruce Bullock,et al.  Risk of What , 1986 .

[38]  M. T. Medina,et al.  Prevalence, Incidence, and Etiology of Epilepsies in Rural Honduras: The Salamá Study , 2005, Epilepsia.

[39]  B. Neville,et al.  Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors , 2008, The Lancet Neurology.

[40]  Timothy A. Pedley,et al.  Epilepsy : a comprehensive textbook , 2008 .

[41]  Josemir W Sander,et al.  Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China , 2006, The Lancet Neurology.

[42]  A. Ngugi,et al.  The epilepsy treatment gap in developing countries: A systematic review of the magnitude, causes, and intervention strategies , 2008, Epilepsia.

[43]  Rakesh K. Gupta,et al.  Neurocysticercosis in patients with active epilepsy from the pig farming community of Lucknow district, north India. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[44]  Josemir W Sander,et al.  The prevalence and treatment gap in epilepsy in China , 2003, Neurology.

[45]  G. Román,et al.  Epidemiology of epilepsy in developing countries. , 1993, Bulletin of the World Health Organization.

[46]  İ. Bora,et al.  Prevalence of Epilepsy in Bursa City Center, an Urban Area of Turkey , 2006, Epilepsia.

[47]  L. Moulton,et al.  A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. , 2004, The New England journal of medicine.

[48]  W. Hauser,et al.  Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[49]  B. Neville,et al.  Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial , 2006, BMJ : British Medical Journal.

[50]  M. Banerjee,et al.  Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: An 8 year randomised study , 2007, Journal of Clinical Neuroscience.

[51]  Josemir W Sander.  Global Campaign Against Epilepsy. Overview of the demonstration projects. , 2002, Epilepsia.

[52]  B. Bergman-Marković,et al.  Prevalence of epilepsy in Croatia: a population‐based survey , 2007, Acta neurologica Scandinavica.

[53]  J. Murthy,et al.  Some Problems and Pitfalls in Developing Countries , 2003, Epilepsia.

[54]  K. Thennarasu,et al.  Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cysticercal lesion: Effect on long-term seizure outcome , 2009, Journal of the Neurological Sciences.

[55]  P Jallon,et al.  Mortality of Epilepsy in Developing Countries , 2005, Epilepsia.

[56]  M. Sperling,et al.  Strategies for surgical treatment of epilepsies in developing countries , 2008, Epilepsia.

[57]  Marcelo,et al.  Prognosis of epilepsy in a community‐based study: 8 years of follow‐up in an Argentine community , 2005, Acta neurologica Scandinavica.

[58]  Validación de un cuestionario para el diagnóstico de la epilepsia en servicios de atención primaria , 2006 .

[59]  C. Mandlhate,et al.  Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study , 2005, Seizure.